LAY LINE GENOMICS S.p.A.
Pomezia (RM), IT
|LAY LINE GENOMICS S.p.A. Patent applications|
|Patent application number||Title||Published|
|20120213784||METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN - According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.||08-23-2012|
|20110206682||MONOCLONAL ANTIBODIES, SYNTHETIC AND BIOTECHNOLOGICAL DERIVATIVES THEREOF ACTING AS NGF-ANTAGONIST MOLECULES - Monoclonal antibodies, synthetic and biotechnological derivatives thereof (ScFv or others) are able to recognise the NGF high affinity receptor, TrkA, and act as NGF-antagonist molecules. Pharmacological compositions for therapy, gene therapy, diagnostics of neurological pathologies are also described. Transgenic animal models to study such pathologies are also described.||08-25-2011|
|20110145941||ANTIBODIES AND DERIVATIVES THEREOF - An anti-TrkA antibody is provided that comprises:||06-16-2011|
|20110105727||Method for the humanization of antibodies and humanized antibodies thereby obtained - Method for the humanization of the VII and VL variable regions of an animal antibody of known sequence, humanized animal antibody obtainable according to the method, in particular anti-NGF and anti-TrkA humanized animal antibodies.||05-05-2011|
|20090123464||Method for the potentiation of opioid analgesics effects on pain - According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.||05-14-2009|
Patent applications by LAY LINE GENOMICS S.p.A.